Posts by Amy M. Yule, MD
-
Treatment for Substance Use Disorder Reduces Risk of Overdose in Young Adults
In young adults, the most significant predictors of overdose after treatment for substance use disorder are a history of intravenous drug use and mood dysregulation—and the first year after the initial evaluation is the riskiest period. However, engagement in treatment has been found to reduce this risk.
-
Exposure to Maternal Substance Use Disorder Increases Risk of Alcohol Use Disorder in Young Adults
In the largest study of its kind, psychiatrists at Massachusetts General Hospital have presented evidence that, independent of ADHD status, young adults who lived with a mother who had a substance use disorder are at increased risk of developing the disorder themselves.
-
Youth with Substance Use Disorders Should Be Screened for Overdose Risk Factors
Psychiatrists at Massachusetts General Hospital have uncovered risk factors for nonfatal drug overdose among young adults being treated for substance use disorder.
Biography
Dr. Amy Yule received her undergraduate degree from the University of California San Diego. She attended the David Geffen School of Medicine at University of California Los Angeles. Dr. Yule completed her adult and child psychiatry training at Massachusetts General Hospital and McLean Hospital. She completed her addiction psychiatry training in the Partners Hospital program. She is the medical director of the Addiction Recovery Management Service at Massachusetts General Hospital where she works with youth ages 14 to 26 with substance use disorders and co-occurring psychiatric illness and their families. She is also an instructor in psychiatry at Harvard Medical School.
In addition to providing clinical care Dr. Yule is involved in clinical research. She has been the recipient of grant funding from the American Academy of Child and Adolescent Psychiatry, the Massachusetts General Hospital Louis V. Gerstner research scholar award, and the National Institute of Drug Abuse. Her research interests include the investigation of risk factors for adolescent onset substance use disorders, risk factors associated with risky behaviors in youth with substance use disorders such as overdose, and the impact of medication treatment for youth with substance use disorders and co-occurring psychiatric illness. She is currently the primary investigator for a study evaluating the effect of treatment with quetiapine (seroquel) for youth with a substance use disorder and bipolar disorder.